More
Optimizing Heart Failure Therapy
Shape Medical Systems cardiopulmonary gas exchange predictive modeling technology brings the early detection and therapeutic outcome assessment of heart and lung disease right to the physician's office.
The Shape-HF™ CPX system uses a state-of-the-art ventilation gas exchange analyzer and proprietary software to:
- Accurately assess cardiopulmonary function and define the probable source of current or future heart and/or lung limitations;
- Assess patient functional capacity;
- Quantify a patient's prognosis and predict future risk of morbidity and mortality;
- Monitor a patient's ongoing clinical response to therapy; and
- Provide real time physiological response to changes in A/V and V/V delay settings in CRT/ICD therapy.
Innovative, easy-to-use, cost effective
The Shape-HF system is innovative, intuitive, cost effective and fully reimbursable. The test is easy to perform, and results are easy to interpret. The Shape-HF system helps physicians by giving objective physiological data needed to accurately assess therapy response, stratify risk, and predict patient outcome.
